Catalyst Crew Technologies Corp. has announced the assignment of intellectual property assets to its wholly-owned Venezuelan operating subsidiary, Inversiones Long 33, C.A. The intellectual property, previously held by Chief Executive Officer Dr. Kevin Rodan Levy, consists of three patents registered in Venezuela covering proprietary technologies referred to as CardioAI, PulmoAI, and NeuroAI. These assets are designed to support data-driven healthcare analytics, predictive modeling, and clinical decision-support applications.
This assignment represents a continued step in the Company's effort to align its intellectual property with its operating structure, positioning the subsidiary to serve as the primary development and commercialization vehicle for its technology platform in the region. The Company believes that consolidating its intellectual property at the operating level enhances strategic flexibility, supports regulatory alignment, and may facilitate future partnerships, licensing opportunities, and regional expansion initiatives. According to Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., "Aligning our intellectual property within our operating structure is an important step as we continue building our platform. Establishing a clear foundation around our core technologies allows us to move forward with development, partnerships, and, where appropriate, broader intellectual property protection strategies across additional markets."
The Company continues to advance the development of its digital health and artificial intelligence platform, with a focus on scalable healthcare solutions, including telehealth infrastructure, remote patient monitoring, and advanced healthcare analytics designed to improve access, efficiency, and care coordination. In addition, the Company intends to pursue expanded intellectual property protection for its technologies in additional jurisdictions worldwide, as practical, in support of long-term platform development and potential international deployment. For more information, please visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.
